ABOUT THE EVENT
Date: Wednesday, September 2, 2026 8am–6:10pm PDT
Event Location: San Francisco, California
Imagine a day spent alongside leaders advancing the future of oligonucleotide and peptide therapeutics, bringing together scientists, innovators, and decision-makers from across pharma and biotech. That is what the Oligonucleotides & Peptides Xchange San Francisco 2026 offers. This invitation-only, highly curated meeting provides access to senior expertise and the opportunity to build meaningful relationships that can influence discovery, delivery, and manufacturing strategies.
Across dedicated tracks including Peptide Discovery and Design, Peptide Delivery and Targeting, Peptide CMC and Manufacturing, Oligonucleotide Delivery, and Oligonucleotide CMC and Quality, attendees will explore the scientific and technical challenges of bringing these complex modalities from concept to clinic. Discussions span areas such as delivery technologies, synthesis and purification, scale-up, analytical development, and quality control, all grounded in real-world experience and current industry demands.
The agenda is designed to maximise interaction and value, combining keynote and spotlight presentations, poster sessions, expert-led roundtables, and pre-scheduled one-to-one meetings. Structured networking throughout the day ensures ample opportunity to exchange insights, benchmark approaches, and identify high-value collaborations within a focused peer group.
Taking place in San Francisco on 3rd September 2026, at the DoubleTree by Hilton
San Francisco Airport Hotel this Xchange connects a senior community working at the forefront of oligonucleotide and peptide therapeutics. Registration is complimentary for qualified attendees.
